ALNYLAM PHARMACEUTICALS, INC. (ALNY) Capital expenditures 2016–2025
ALNYLAM PHARMACEUTICALS, INC. (ALNY) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$58.7MFY2025 · since FY2016: $64.6M → $58.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $58.7M | +71.2% |
| FY2024 | $34.3M | -44.9% |
| FY2023 | $62.2M | -13.7% |
| FY2022 | $72.1M | -5.6% |
| FY2021 | $76.4M | +8.5% |
| FY2020 | $70.4M | -49.8% |
| FY2019 | $140.2M | +10.5% |
| FY2018 | $126.9M | +21.8% |
| FY2017 | $104.2M | +61.4% |
| FY2016 | $64.6M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice